Sona Academy's Winter School of Reproductologist: LH as a key to ART success

New Horizons in Personalization

This month, initiated by Sona-Pharm, the annual Winter School of Reproductologist brought together reproductive medicine specialists for a focused professional dialogue on one of the key questions in modern fertility treatment.

Organized jointly with Sona Academy, part of Sona Group, and the Ukrainian Association of Reproductive Medicine (UARM), the event focused on "LH as a key to ART success: new horizons of personalization." It brought together practicing reproductive specialists. Among the speakers and attendees were medical directors and CEOs of leading reproductive medicine clinics in the country.

What makes this event especially important is that it goes far beyond both promotional communication and formal education. It is a space for deep professional exchange built around real clinical practice, live discussion, and shared expertise among doctors who work with complex reproductive cases every day.

This year's program focused on the role of LH in stimulation protocols and explored the topic from several angles — from basic physiology and receptor-level mechanisms to clinical challenges in different patient groups and practical decisions around trigger choice, random-start protocols, cryo protocols, and pharmacoeconomics.

A particularly important part of the event was the discussion of real clinical cases. Among the topics raised were poor responders, dual trigger, the POSEIDON classification, androgen priming, oncofertility, and even the role of AI in reproductive genetics. This is exactly the kind of dialogue that helps turn expert exchange into a true community of practice.

We believe that after meetings like this, doctors return to their clinics not only with new ideas, but with practical tools that help improve treatment outcomes, refine protocol selection, and optimize care without compromising quality. For the professional community, this is also another step toward stronger shared standards and deeper collaboration in reproductive medicine in Ukraine.

We would also like to thank our team members Vlad Golovinov, MBA, and Olena Rostokina for their engagement and contribution to making this event possible, and express our special gratitude to Mykola Gryshchenko — Professor, Doctor of Medical Sciences, MBA, Director of the Clinic of Reproductive Medicine named after Academician V.I. Gryshchenko and Vice President of UARM — for his initiative and for organizing this event.